JAGSONPAL PHARMACEUTICALS

JAGSNPHARM

Small Cap | Pharmaceuticals
₹206.21
-1.06 (-0.51%)

Stock price as on 15 May 2026 at 15:30 PM

Jagsonpal pharmaceuticals share price update

As of the latest trading session, Jagsonpal Pharmaceuticals share price is currently at ₹206.21, which is down by ₹-1.06 from its previous closing. To...

Jagsonpal Pharmaceuticals stock performance

Today’s low

₹205.42

Today’s high

₹210

₹206.21

52 week low

₹155

52 week high

₹301.65

₹206.21
Open
₹206.00
Previous close
₹207.28
Share volume
31,158
Total traded value (Lakh)
₹64.25
Upper circuit
₹248.73
Lower circuit
₹165.83

Jagsonpal Pharmaceuticals fundamentals

Market cap (Cr)
₹1,384.50
P/E ratio (TTM)
32.17
Book value per share
₹41.13
Beta
0.54
Return on equity
18.58%
Earnings per share (TTM)
₹6.65
Dividend yield
1.93%
Net profit/quarter (Cr)
₹8.76

Jagsonpal Pharmaceuticals technical summary

₹206.21
-0.51 ▼
7
Bearish
9
Bullish
5 Day208.7
10 Day208.8
12 Day208.3
20 Day205.4
26 Day203.1
50 Day196.7
100 Day194.9
200 Day200.1
5 Day209.1
10 Day210.7
12 Day210.5
20 Day205.5
26 Day202.8
50 Day192.1
100 Day186.1
200 Day208.2

208.24

PIVOT

First support
₹204.71
First resistance
₹210.82
Second support
₹202.13
Second resistance
₹214.35
Third support
₹198.60
Third resistance
₹216.93
RSI
54.39
ADX
39.47
MACD
5.14
Williams % R
-67.88
Commodity Channel Index (CCI)
16.54
Date
15 May 2026
Same day
18,522
Week
56,051
Month
1,08,150
1 year
0.54
3 years
1.09
Over 1 month
6.03%
Over 1 year
-5.96%
Over 3 months
18.85%
Over 3 years
14.99%
Over 6 months
-1.87%
Over 6 years
40.03%

Investment Returns

Over 1 Month6.03%
Over 3 Months18.85%
Over 6 Months1.87%
Over 1 Year5.96%

Jagsonpal Pharmaceuticals Shareholding pattern


Public
29.44%
Promoter holdings
67.88%
FII
2.44%
DII
0.22%
Promoter shares
0%
Promoter sharesShareCategory

Aresko Progressive Private Limited (trustee Of Aresko Progressive Trust, A In The Capacity Of Repres

1,33,35,635 (19.92%)

Shareholding of Promoter and Promoter Group

Infinity Capital (formerly Infinity Holdings Sidecar1)

1,18,88,250 (17.75%)

Shareholding of Promoter and Promoter Group

Infinity Holdings

1,10,32,550 (16.48%)

Shareholding of Promoter and Promoter Group

Infinity Portfolio Holdings

57,17,950 (8.54%)

Shareholding of Promoter and Promoter Group

Rajpal Singh Kochhar

30,30,400 (4.53%)

Shareholding of Promoter and Promoter Group

Promoter sharesShareCategory
Aresko Progressive Private Limited (trustee Of Aresko Progressive Trust, A In The Capacity Of Repres1,33,35,635 (19.92%)Shareholding of Promoter and Promoter Group
Infinity Capital (formerly Infinity Holdings Sidecar1)1,18,88,250 (17.75%)Shareholding of Promoter and Promoter Group
Infinity Holdings1,10,32,550 (16.48%)Shareholding of Promoter and Promoter Group
Infinity Portfolio Holdings57,17,950 (8.54%)Shareholding of Promoter and Promoter Group
Rajpal Singh Kochhar30,30,400 (4.53%)Shareholding of Promoter and Promoter Group
Manish Gupta18,21,512 (2.72%)Public Shareholding
Authum Investment And Infrastructure Limited9,67,965 (1.45%)Public Shareholding
Sanjiv Kumar Dudeja9,26,360 (1.38%)Public Shareholding
Lincoln P Coelho7,75,500 (1.16%)Public Shareholding
Prithipal Singh Kochhar2,69,675 (0.4%)Shareholding of Promoter and Promoter Group
Inderpal Singh Kochhar1,83,750 (0.27%)Shareholding of Promoter and Promoter Group

About JAGSONPAL PHARMACEUTICALS

Promoted by Rajpal Singh Kochhar in August, 1978, Jagsonpal Pharmaceuticals Limited is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana. The Company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs. Simultaneously, it has geared up to set up an ultra modern multi-purpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd. The company has a strategic alliance with Fidia Spa, Italy;

Parent Organisation

Indian Private

NSE Symbol

JAGSNPHARM

Founded

1978

JAGSONPAL PHARMACEUTICALS CORPORATE ACTION

Dividend dateDividend amountDividend typeRecord dateInstrument type
12 Sept 20252.5Final12 Sept 2025Equity shares
06 Sept 20245Final06 Sept 2024Equity shares
21 Aug 20235Final21 Aug 2023Equity shares
29 Oct 20214Interim01 Nov 2021Equity shares
22 Sept 20211Final24 Sept 2021Equity shares
22 Sept 20200.5Final24 Sept 2020Equity shares
20 Sept 20190.25Final24 Sept 2019Equity shares
18 Sept 20180.1Final21 Sept 2018Equity shares
21 Sept 20170.1Final23 Sept 2017Equity shares
21 Sept 20160.1Final23 Sept 2016Equity shares
21 Sept 20150.1Final23 Sept 2015Equity shares
25 Sept 20140.5Final27 Sept 2014Equity shares
25 Sept 20130.5Final27 Sept 2013Equity shares
21 Sept 20125Final25 Sept 2012Equity shares
23 Sept 20110.5Final27 Sept 2011Equity shares
21 Sept 20100.5Final23 Sept 2010Equity shares
23 Sept 20090.25Final25 Sept 2009Equity shares
24 Sept 20080.1Final26 Sept 2008Equity shares
21 Sept 20070.1Final25 Sept 2007Equity shares
26 Sept 20050Final28 Sept 2005Equity shares

View more stocks

What’s trending

All stocks

REMUS

REMUS PHARMACEUTICALS L

865.25
+144.2 (+20%)
HARDCAS

HARDCASTLE & WAUD MFG.CO.LTD.

877.8
+146.3 (+20%)
WAKEFIT

WAKEFIT INNOVATIONS LIMITED

143.75
+23.8 (+19.84%)
WAKEFIT

WAKEFIT INNOVATIONS LTD

143.25
+23.61 (+19.73%)
View all

Top gainers

ADANIENT

ADANI ENTERPRISES LIMITED

2716
+280.40 (+11.51%)
TMPV

TATA MOTORS PASS VEH LTD

356.55
+17.80 (+5.25%)
DRREDDY

DR. REDDY S LABORATORIES

1336.7
+33.10 (+2.54%)
INFY

INFOSYS LIMITED

1119
+24.00 (+2.19%)
View all

Top losers

HINDALCO

HINDALCO INDUSTRIES LTD

1067.5
-35.80 (-3.24%)
NESTLEIND

NESTLE INDIA LIMITED

1430.5
-29.10 (-1.99%)
TATASTEEL

TATA STEEL LIMITED

216.84
-4.29 (-1.94%)
ETERNAL

ETERNAL LIMITED

241.18
-4.64 (-1.89%)
View all

Frequently asked questions



Related tags


You are here


Related links


Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer

Powered by Bajaj Financial Securities Limited (Bajaj Broking)